These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 27744317

  • 21. Single-cell spatial transcriptomics reveals a dystrophic trajectory following a developmental bifurcation of myoblast cell fates in facioscapulohumeral muscular dystrophy.
    Chen L, Kong X, Johnston KG, Mortazavi A, Holmes TC, Tan Z, Yokomori K, Xu X.
    Genome Res; 2024 Jun 25; 34(5):665-679. PubMed ID: 38777608
    [Abstract] [Full Text] [Related]

  • 22. Testing the effects of FSHD candidate gene expression in vertebrate muscle development.
    Wuebbles RD, Long SW, Hanel ML, Jones PL.
    Int J Clin Exp Pathol; 2010 Mar 28; 3(4):386-400. PubMed ID: 20490329
    [Abstract] [Full Text] [Related]

  • 23. Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.
    Ansseau E, Eidahl JO, Lancelot C, Tassin A, Matteotti C, Yip C, Liu J, Leroy B, Hubeau C, Gerbaux C, Cloet S, Wauters A, Zorbo S, Meyer P, Pirson I, Laoudj-Chenivesse D, Wattiez R, Harper SQ, Belayew A, Coppée F.
    PLoS One; 2016 Mar 28; 11(1):e0146893. PubMed ID: 26816005
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.
    Himeda CL, Debarnot C, Homma S, Beermann ML, Miller JB, Jones PL, Jones TI.
    Mol Cell Biol; 2014 Jun 28; 34(11):1942-55. PubMed ID: 24636994
    [Abstract] [Full Text] [Related]

  • 28. Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.
    Broucqsault N, Morere J, Gaillard MC, Dumonceaux J, Torrents J, Salort-Campana E, Maues De Paula A, Bartoli M, Fernandez C, Chesnais AL, Ferreboeuf M, Sarda L, Dufour H, Desnuelle C, Attarian S, Levy N, Nguyen K, Magdinier F, Roche S.
    Hum Mol Genet; 2013 Oct 15; 22(20):4206-14. PubMed ID: 23777630
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.
    Dmitriev P, Petrov A, Ansseau E, Stankevicins L, Charron S, Kim E, Bos TJ, Robert T, Turki A, Coppée F, Belayew A, Lazar V, Carnac G, Laoudj D, Lipinski M, Vassetzky YS.
    J Biol Chem; 2011 Dec 30; 286(52):44620-31. PubMed ID: 21937448
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.
    Moyle LA, Blanc E, Jaka O, Prueller J, Banerji CR, Tedesco FS, Harridge SD, Knight RD, Zammit PS.
    Elife; 2016 Nov 14; 5():. PubMed ID: 27841748
    [Abstract] [Full Text] [Related]

  • 35. Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures.
    Lim JW, Wong CJ, Yao Z, Tawil R, van der Maarel SM, Miller DG, Tapscott SJ, Filippova GN.
    Hum Mol Genet; 2018 Aug 01; 27(15):2644-2657. PubMed ID: 29741619
    [Abstract] [Full Text] [Related]

  • 36. Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2.
    Lemmers RJ, van der Vliet PJ, Balog J, Goeman JJ, Arindrarto W, Krom YD, Straasheijm KR, Debipersad RD, Özel G, Sowden J, Snider L, Mul K, Sacconi S, van Engelen B, Tapscott SJ, Tawil R, van der Maarel SM.
    Eur J Hum Genet; 2018 Jan 01; 26(1):94-106. PubMed ID: 29162933
    [Abstract] [Full Text] [Related]

  • 37. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle.
    Yao Z, Snider L, Balog J, Lemmers RJ, Van Der Maarel SM, Tawil R, Tapscott SJ.
    Hum Mol Genet; 2014 Oct 15; 23(20):5342-52. PubMed ID: 24861551
    [Abstract] [Full Text] [Related]

  • 38. Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD).
    Ansseau E, Vanderplanck C, Wauters A, Harper SQ, Coppée F, Belayew A.
    Genes (Basel); 2017 Mar 03; 8(3):. PubMed ID: 28273791
    [Abstract] [Full Text] [Related]

  • 39. Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs.
    Zeng W, Chen YY, Newkirk DA, Wu B, Balog J, Kong X, Ball AR, Zanotti S, Tawil R, Hashimoto N, Mortazavi A, van der Maarel SM, Yokomori K.
    Hum Mutat; 2014 Aug 03; 35(8):998-1010. PubMed ID: 24838473
    [Abstract] [Full Text] [Related]

  • 40. Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene.
    Nguyen TH, Paprzycki L, Legrand A, Declèves AE, Heher P, Limpens M, Belayew A, Banerji CRS, Zammit PS, Tassin A.
    Skelet Muscle; 2023 Dec 16; 13(1):21. PubMed ID: 38104132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.